| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatitis, Acute Necrotizing | D019283 | 18 associated lipids |
| Parkinsonian Disorders | D020734 | 20 associated lipids |
| Neuralgia | D009437 | 28 associated lipids |
| Fibromyalgia | D005356 | 4 associated lipids |
| Hypoxia-Ischemia, Brain | D020925 | 22 associated lipids |
| Intestinal Pseudo-Obstruction | D007418 | 5 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Bulimia | D002032 | 3 associated lipids |
| Sleep Deprivation | D012892 | 5 associated lipids |
| Urinary Incontinence | D014549 | 4 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Smart D et al. | 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. | 2002 | Br. J. Pharmacol. | pmid:12023948 |
| Farquhar-Smith WP et al. | Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. | 2002 | Pain | pmid:12031775 |
| Porter AC et al. | Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. | 2002 | J. Pharmacol. Exp. Ther. | pmid:12023533 |
| Kirkham TC et al. | Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. | 2002 | Br. J. Pharmacol. | pmid:12055133 |
| Vinklerová J et al. | Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. | 2002 | J. Psychopharmacol. (Oxford) | pmid:12095072 |
| Williams CM and Kirkham TC | Observational analysis of feeding induced by Delta9-THC and anandamide. | 2002 | Physiol. Behav. | pmid:12044596 |
| Kreitzer AC and Regehr WG | Retrograde signaling by endocannabinoids. | 2002 | Curr. Opin. Neurobiol. | pmid:12049940 |
| Maccarrone M et al. | Endocannabinoid degradation, endotoxic shock and inflammation. | 2002 | Curr Drug Targets Inflamm Allergy | pmid:14561206 |
| Wallace MJ et al. | Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. | 2002 | Eur. J. Pharmacol. | pmid:12359270 |
| Roberts LA et al. | Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. | 2002 | Br. J. Pharmacol. | pmid:12359623 |
| Oz M et al. | Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. | 2002 | Synapse | pmid:12325042 |
| Ralevic V et al. | Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. | 2002 | Life Sci. | pmid:12354577 |
| Laine K et al. | Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:12356827 |
| Barthó L et al. | Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. | 2002 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:12382081 |
| Darmani NA | The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. | 2002 | J. Pharmacol. Exp. Ther. | pmid:11752094 |
| Mascolo N et al. | The endocannabinoid system and the molecular basis of paralytic ileus in mice. | 2002 | FASEB J. | pmid:12397089 |
| Mukhopadhyay S et al. | Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12003810 |
| Wiley JL and Martin BR | Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. | 2002 | Chem. Phys. Lipids | pmid:12505690 |
| Schmid HH et al. | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. | 2002 | Chem. Phys. Lipids | pmid:12505695 |
| Cravatt BF and Lichtman AH | The enzymatic inactivation of the fatty acid amide class of signaling lipids. | 2002 | Chem. Phys. Lipids | pmid:12505696 |
| Paria BC et al. | Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. | 2002 | Chem. Phys. Lipids | pmid:12505701 |
| Kozak KR et al. | Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. | 2002 | J. Biol. Chem. | pmid:12244105 |
| Burstein SH et al. | Regulation of anandamide tissue levels by N-arachidonylglycine. | 2002 | Biochem. Pharmacol. | pmid:12234618 |
| Lin YS and Lee LY | Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. | 2002 | J. Physiol. (Lond.) | pmid:11897863 |
| Walter L et al. | Astrocytes in culture produce anandamide and other acylethanolamides. | 2002 | J. Biol. Chem. | pmid:11916961 |
| Begg M et al. | Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. | 2002 | Eur. J. Pharmacol. | pmid:11755170 |
| Ros J et al. | Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. | 2002 | Gastroenterology | pmid:11781284 |
| Lever IJ and Malcangio M | CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. | 2002 | Br. J. Pharmacol. | pmid:11786475 |
| Molderings GJ et al. | Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. | 2002 | Neurochem. Int. | pmid:11738482 |
| Martin BR et al. | Assessment of structural commonality between tetrahydrocannabinol and anandamide. | 2002 | Eur. J. Pharmacol. | pmid:11790376 |
| Mechoulam R et al. | Cannabinoids and brain injury: therapeutic implications. | 2002 | Trends Mol Med | pmid:11815270 |
| Laine K et al. | Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:11818382 |
| Maccarrone M et al. | Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. | 2002 | Mol. Hum. Reprod. | pmid:11818522 |
| Di Marzo V et al. | A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. | 2002 | J. Pharmacol. Exp. Ther. | pmid:11861807 |
| Barnett-Norris J et al. | Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. | 2002 | J. Med. Chem. | pmid:12166938 |
| Habayeb OM et al. | Endogenous cannabinoids: metabolism and their role in reproduction. | 2002 | Life Sci. | pmid:12148689 |
| Szallasi A | Vanilloid (capsaicin) receptors in health and disease. | 2002 | Am. J. Clin. Pathol. | pmid:12109845 |
| Dinh TP et al. | Brain monoglyceride lipase participating in endocannabinoid inactivation. | 2002 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12136125 |
| Liu WM et al. | Effects of anandamide on embryo implantation in the mouse. | 2002 | Life Sci. | pmid:12137909 |
| Di Marzo V et al. | Endovanilloid signaling in pain. | 2002 | Curr. Opin. Neurobiol. | pmid:12139983 |
| Matias I et al. | Presence and regulation of the endocannabinoid system in human dendritic cells. | 2002 | Eur. J. Biochem. | pmid:12153574 |
| Schäbitz WR et al. | Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. | 2002 | Stroke | pmid:12154273 |
| Costa B et al. | Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. | 2002 | Eur. J. Pharmacol. | pmid:12163107 |
| de Lago E et al. | UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. | 2002 | Eur. J. Pharmacol. | pmid:12163112 |
| Andersson DA et al. | Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. | 2002 | Mol. Pharmacol. | pmid:12181448 |
| Chemin J et al. | Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. | 2002 | J. Neurosci. | pmid:12177183 |
| Gubellini P et al. | Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | 2002 | J. Neurosci. | pmid:12177188 |
| Gardiner SM et al. | Complex regional haemodynamic effects of anandamide in conscious rats. | 2002 | Br. J. Pharmacol. | pmid:11959791 |
| Jerman JC et al. | Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. | 2002 | Br J Anaesth | pmid:12453933 |
| Jia Y et al. | Anandamide induces cough in conscious guinea-pigs through VR1 receptors. | 2002 | Br. J. Pharmacol. | pmid:12411414 |